Androgen deprivation therapy and side effects: are GnRH antagonists safer?

Androgen deprivation therapy (ADT) with gonadotropin-releasing hormone (GnRH) agonists and antagonists is the mainstay of advanced prostate cancer treatment. Both drug classes decrease levels of luteinizing hormone and follicle-stimulating hormones (FSH), thereby lowering testosterone to castrate le...

Descripción completa

Detalles Bibliográficos
Autores principales: Freedland, Stephen J, Abrahamsson, Per-Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831824/
https://www.ncbi.nlm.nih.gov/pubmed/32655041
http://dx.doi.org/10.4103/aja.aja_22_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831824/
https://www.ncbi.nlm.nih.gov/pubmed/32655041
http://dx.doi.org/10.4103/aja.aja_22_20

Ejemplares similares